Login to Your Account



GSK Licenses Another Program As Part Of Theravance Alliance

By Aaron Lorenzo


Wednesday, March 23, 2005
Theravance Inc. could receive in excess of $252 million under terms of a new license agreement with a familiar partner, GlaxoSmithKline plc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription